abstract |
The present invention relates to the compound of general formula (I), wherein Rn 1 , Rn 2 , Rn 2a and Rn 3 have the implication described in claim 1, it is the inhibitor of PDK1 and cell proliferation/cell vitality, may be used for oncotherapy. |